Cannabinoid research is developing rapidly.
There are established medical uses for certain cannabinoid-based prescription medicines. For example, the FDA has approved a purified CBD prescription medicine for specific seizure disorders. Other cannabinoid-related prescription medicines have also been approved for particular medical conditions.
At the same time, research into many other potential applications remains ongoing.
This distinction is particularly important for consumers:
Research interest ≠ proven treatment.
A laboratory study, early clinical study, or promising finding does not automatically mean that a commercial hemp or CBD product can prevent, treat, or cure a disease.
Responsible hemp businesses should therefore avoid exaggerated medical claims and instead communicate what is actually known.